Tweet
Associated Banc Corp lifted its stake in Stryker Co. (NYSE:SYK) by 12.2% in the second quarter, HoldingsChannel.com reports. The firm owned 2,994 shares of the medical technology company's stock after buying an additional 325 shares during the period. Associated Banc Corp's holdings in Stryker were worth $506,000 at the end of the most recent quarter.
Several other institutional investors also recently made changes to their positions in SYK. Bellevue Group AG lifted its stake in shares of Stryker by 4.8% during the 2nd quarter. Bellevue Group AG now owns 118,770 shares of the medical technology company's stock worth $20,056,000 after acquiring an additional 5,470 shares during the last quarter. ST Germain D J Co. Inc. bought a new stake in shares of Stryker during the 2nd quarter worth approximately $292,000. Trust Co. of Virginia VA bought a new stake in shares of Stryker during the 2nd quarter worth approximately $930,000. Cedar Capital LLC lifted its stake in shares of Stryker by 49.3% during the 2nd quarter. Cedar Capital LLC now owns 2,200 shares of the medical technology company's stock worth $371,000 after acquiring an additional 726 shares during the last quarter. Finally, Penobscot Investment Management Company Inc. lifted its stake in shares of Stryker by 3.2% during the 2nd quarter. Penobscot Investment Management Company Inc. now owns 36,855 shares of the medical technology company's stock worth $6,223,000 after acquiring an additional 1,145 shares during the last quarter. Hedge funds and other institutional investors own 74.40% of the company's stock. Get Stryker alerts:
Shares of NYSE SYK opened at $168.69 on Friday. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.83 and a quick ratio of 1.15. The firm has a market cap of $62.04 billion, a price-to-earnings ratio of 25.96, a PEG ratio of 2.35 and a beta of 0.62. Stryker Co. has a twelve month low of $137.70 and a twelve month high of $179.84. Stryker (NYSE:SYK) last issued its earnings results on Tuesday, July 24th. The medical technology company reported $1.76 earnings per share for the quarter, beating the Zacks' consensus estimate of $1.73 by $0.03. The business had revenue of $3.32 billion during the quarter, compared to analyst estimates of $3.31 billion. Stryker had a return on equity of 26.93% and a net margin of 8.28%. Stryker's revenue was up 10.3% on a year-over-year basis. During the same period in the previous year, the company posted $1.53 EPS. research analysts expect that Stryker Co. will post 7.25 earnings per share for the current fiscal year.
A number of equities research analysts recently issued reports on SYK shares. Zacks Investment Research raised Stryker from a "hold" rating to a "buy" rating and set a $192.00 price target for the company in a research note on Monday, May 21st. Canaccord Genuity raised their price target on Stryker from $176.00 to $185.00 and gave the stock a "buy" rating in a research note on Friday, April 27th. Stifel Nicolaus raised their price target on Stryker from $183.00 to $187.00 and gave the stock a "buy" rating in a research note on Friday, April 27th. ValuEngine raised Stryker from a "hold" rating to a "buy" rating in a research note on Tuesday, June 26th. Finally, Royal Bank of Canada reissued a "buy" rating and set a $184.00 price target on shares of Stryker in a research note on Wednesday, July 25th. One analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have assigned a buy rating to the company. Stryker presently has a consensus rating of "Buy" and a consensus target price of $176.43.
Stryker Company Profile
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties.
Recommended Story: Investing in Growth Stocks
Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Co. (NYSE:SYK). Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter 